- Home
- SBFM vs SXTP Comparison
SBFM vs SXTP Comparison
Compare SBFM & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- SXTP
- Stock Information
- Founded
- SBFM 2006
- SXTP 2010
- Country
- SBFM United States
- SXTP United States
- Employees
- SBFM N/A
- SXTP N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- SXTP Health Care
- Exchange
- SBFM Nasdaq
- SXTP Nasdaq
- Market Cap
- SBFM 6.6M
- SXTP 5.9M
- IPO Year
- SBFM N/A
- SXTP 2023
- Fundamental
- Price
- SBFM $1.50
- SXTP $1.40
- Analyst Decision
- SBFM Strong Buy
- SXTP Buy
- Analyst Count
- SBFM 1
- SXTP 2
- Target Price
- SBFM $15.00
- SXTP $3.00
- AVG Volume (30 Days)
- SBFM 44.5K
- SXTP 72.2K
- Earning Date
- SBFM 11-04-2025
- SXTP 11-13-2025
- Dividend Yield
- SBFM N/A
- SXTP N/A
- EPS Growth
- SBFM N/A
- SXTP N/A
- EPS
- SBFM N/A
- SXTP N/A
- Revenue
- SBFM $36,341,741.00
- SXTP $984,494.00
- Revenue This Year
- SBFM $32.20
- SXTP $81.41
- Revenue Next Year
- SBFM $32.74
- SXTP $95.63
- P/E Ratio
- SBFM N/A
- SXTP N/A
- Revenue Growth
- SBFM 19.22
- SXTP 128.70
- 52 Week Low
- SBFM $1.17
- SXTP $1.22
- 52 Week High
- SBFM $3.90
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- SBFM 56.84
- SXTP 48.27
- Support Level
- SBFM $1.35
- SXTP $1.33
- Resistance Level
- SBFM $1.45
- SXTP $1.45
- Average True Range (ATR)
- SBFM 0.07
- SXTP 0.09
- MACD
- SBFM 0.01
- SXTP 0.02
- Stochastic Oscillator
- SBFM 82.39
- SXTP 60.66
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.